Dr. John Cush RheumNow
5 years 10 months ago
View one of our fantastic #ACR20 video titled "Staying on Therapy in RA" with Dr. Janet Pope ( @Janetbirdope)
https://t.co/imCpxVs2N8 https://t.co/AcTBGaapig
Dr. John Cush RheumNow
5 years 10 months ago
#BestARC20Tweets
"RT @drdavidliew : Great to sit down with @LCalabreseDO @Sarah_L_Mackie @RichardPAConway a few hours ago and chat about two very interesting GCA therapeutics abstracts: https://t.co/V3fzB0W3Ko
great discussion!
#ACR20 @RheumNow"
Dr. John Cush RheumNow
5 years 10 months ago
Read our article titled: Best Imaging Techniques for non ANCA Vasculitis by Dr. Alexa Meara ( @lexmeara) as discussed at #ACR20 https://t.co/CyfC8bdq42 https://t.co/Ay7Sw0eMTY
Dr. John Cush RheumNow
5 years 10 months ago
What was your favorite abstract or study presented at #ACR20? We've rounded up our top choices. #ACRbest https://t.co/50hpUUSCBD https://t.co/09t2kziLQr
Dr. John Cush RheumNow
5 years 10 months ago
What is the SEAMless transition from combination Etanercept to Methotrexate? with Dr. Jonathan Kay #ACR20
https://t.co/58raeaE8Mr https://t.co/FUIidcoy4I
Dr. John Cush RheumNow
5 years 10 months ago
The #ACR20 convergence highlighted a shift in gout management and uric acid lowering therapy (ULT). Read more about mitigating immunogenicity when using uricase therapies as ULT in an article by Dr. Alexa Meara ( @lexmeara) https://t.co/5AfyFhJGqp https://t.co/Sv1BiI0Uwd
Dr. John Cush RheumNow
5 years 10 months ago
Check out our article titled: FAST, FREED, CARES, & CONFIRMS: A Run-Down on the Black-Box Blues of Febuxostat by Dr. Meral K. El Ramahi ( @MeralElRamahiMD). #ACR20
https://t.co/dKhotXONGP https://t.co/KfsFFX7z0D
Dr. John Cush RheumNow
5 years 10 months ago
Check out our video on representation of women authors in rheumatology: Dr Bella Mehta ( @bella_mehta) #ACR20
https://t.co/4EAiiSwye8 https://t.co/AS1P8IseJT
Dr. John Cush RheumNow
5 years 10 months ago
Improving Drug Adherence in RA: Dr Janet Pope ( @Janetbirdope) Reviews abstract #799 presented at #ACR20.
https://t.co/ONCJmCOdzC https://t.co/ornpQiopTS
Dr. John Cush RheumNow
5 years 10 months ago
Great read! "The Vaccine Review Process and Why You Should Know It" by Dr. Rachel Tate ( @uptoTate)
https://t.co/l39qH3LuXm https://t.co/PR1AaQCD7V
Dr. John Cush RheumNow
5 years 10 months ago
SEAM-RA Trial: Dr. Jeff Curtis ( @RADoctor) discusses abstract # 0939 that looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at #ACR20
https://t.co/2yMyj4BKs1 https://t.co/2gqJM4EKpG
Dr. John Cush RheumNow
5 years 10 months ago
Long-Term Benefits of Ixekizumab in Psoriatic Arthritis
https://t.co/CaGVSvFzVd https://t.co/ktdG5nt96f
Dr. Kathryn Dao reviews abstract L04 - Influenza Adverse Events in Patients with Rheumatoid Arthritis in the Tofacitinib Clinical Program - at the 2020 ACR annual meeting.
Gout has historically been considered a disease of the financially rich, rich in diet, and rich in alcohol. This legacy frequently results in contemporary patients reporting that they are adjusting their diet to try and control their hyperuricaemia and gout, often deferring urate-lowering treatment to attempt this.
